Researchers used machine learning models to assess the physical and primarily mental performance of superagers.
Enlivex’s shares cut in half after ‘biases’ cloud Ph2 cell therapy data in sepsis
Enlivex Therapeutics’ cell therapy has disappointed investors because its impact in a mid-stage test in sepsis was difficult to figure out. The company nonetheless said
April 13, 2024